Over 90% of dementia cases in China are undetected

A survey of 7,072 older adults in six provinces across China, with one rural and one urban community in each province, has identified 359 older adults with dementia and 328 with depression. There were only 26 participants who had doctor-diagnosed dementia reported and 26 who had doctor-diagnosed depression. Overall, 93% of dementia cases and 93% of depression were not detected.

Undetected dementia was strongly associated with low socioeconomic status such as a low educational and occupational class, and living in a rural area.

In comparison, research in high income countries has found that about 60% of older adults with dementia are not diagnosed, and generally there has not been a strong association between low socioeconomic status and undetected dementia. One factor in China’s high rate may be that most older Chinese live with their families, who may be inclined to see dementia as a normal part of aging.

http://www.eurekalert.org/pub_releases/2013-07/kcl-o9072413.php

 

New estimates of dementia in China

A new review of 89 studies, involving more than 340,000 participants in total, has estimated that 9.19 million people in China had dementia in 2010, of whom 5.69 million had Alzheimer’s disease. Previous studies appear to have considerably underestimated the true burden of dementia in China, largely due to limited data availability. However, this study examined a much wider range of data sources than earlier studies, including many Chinese-language reports.

Of the 340 247 participants, 6357 had Alzheimer's disease (1.87%). Of 254,367 assessed for other forms of dementia, 3543 (1.4%) had vascular dementia, frontotemporal dementia, or Lewy body dementia.

Total dementia prevalence in 1990 was 1·8% at 65-69 years, and 42·1% at age 95-99 years; in 2010, prevalence had increased to 2·6% and 60·5%, respectively.

Prevalence was higher for women than men, but didn't differ significantly between urban and rural residents.

http://www.eurekalert.org/pub_releases/2013-06/l-mco060513.php

[3561] Chen, R., Hu Z., Chen R-L., Ma Y., Zhang D., & Wilson K.
(2013).  Determinants for undetected dementia and late-life depression.
The British Journal of Psychiatry. 203(3), 203 - 208.

[3559] Chan, K Y., Wang W., Wu J J., Liu L., Theodoratou E., Car J., et al.
(2013).  Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis.
The Lancet. 381(9882), 2016 - 2023.

Related News

A review of three high quality trials comparing the putative benefits of omega-3 fatty acids for preventing age-related cognitive decline, has concluded that there is no evidence that taking fish oil supplements helps fight cognitive decline.

While the ‘Alzheimer’s gene’ is relatively common — the ApoE4 mutation is present in around 15% of the population — having two copies of the mutation is, thankfully, much rarer, at around 2%.

Dementia is a progressive illness, and its behavioral and psychological symptoms are, for caregivers, the most difficult symptoms to manage.

A study designed to compare the relative benefits of exercise and diet control on Alzheimer’s pathology and cognitive performance has revealed that while both are beneficial, exercise is of greater benefit in reducing Alzheimer’s pathology and cognitive impairment.

I have reported previously on research suggesting that rapamycin, a bacterial product first isolated from soil on Easter Island and used to help transplant patients prevent organ rejection, might improve learning and memory.

Following on from mouse studies, a human study has investigated whether caffeine can help prevent older adults with mild cognitive impairment from progressing to dementia.

A study involving those with a strong genetic risk of developing Alzheimer’s has found that the first signs of the disease can be detected 25 years before symptoms are evident.

A number of studies have come out in recent years linking age-related cognitive decline and dementia risk to inflammation and infection (put inflammation into the “Search this site” box at the top of the page and you’ll see what I mean). New research suggests one important mechanism.

I’ve reported before on the evidence suggesting that carriers of the ‘Alzheimer’s gene’, APOE4, tend to have smaller brain volumes and perform worse on cognitive tests, despite being cognitively ‘normal’.

A new study, involving 1,219 dementia-free older adults (65+), has found that the more omega-3 fatty acids the person consumed, the lower the level of beta-amyloid in the blood (a proxy for brain levels).

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news